George Medicines
George Medicines is an FDA-approved pharmaceutical company developing innovative and accessible treatments for hypertension. The company has created a novel, single-pill therapy that has demonstrated statistically significant improvements in the treatment of hypertension, cardiovascular disease, and stroke.
Widaplik is a first‑in‑class, single‑pill triple combination that tackles one of the biggest challenges in hypertension: most patients still don’t reach or maintain blood pressure control.
By combining telmisartan, amlodipine, and indapamide into one once‑daily tablet, Widaplik is designed to simplify treatment, improve adherence, and deliver more reliable blood pressure reduction.
With millions of patients likely to need two or more medicines, Widaplik has strong potential to become a new standard option for earlier, more effective hypertension management.
